Skip to main content
Premium Trial:

Request an Annual Quote

Really, I'd Love to Give You My Data -- But I Can't

Over at bbgm, Deepak Singh's considering the expansive issue of data ownership and open access. He says that talking this over with people in the field has convinced him that "our problem does not necessarily lie in scientists being inherently protective of their data, but rather to a system that encourages them to do so." Deepak says he believes that it will be possible for institutions to effect this kind of change, but that it will take time for that to happen. "It’s going to take a while, but if pharma companies can agree to share pre-competitive biomarker data, then academics can change as well," he writes.

 

The Scan

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.